Abstract:Purpose: To develop a technique with clinical 3.0-T magnetic resonance (MR) imaging to delineate local contrast agent distribution in coronary artery walls for potential molecular MR imaging-guided local gene or drug therapy of atherosclerotic coronary artery disease.Materials and methods: This animal protocol was approved by the institutional animal care and use committee and was in compliance with the Guide for the Care and Use of Laboratory Animals. For in vitro confirmation, human arterial smooth muscle cells (SMCs) were used to determine capability of SMCs in uptake of motexafin gadolinium (MGd) and its optimal dose. For ex vivo evaluation, a 2-mL mixture of MGd and trypan blue was locally infused into coronary artery walls of six cadaveric pig hearts with MR monitoring and an MR imaging guidewire, surface coils, or both. For in vivo validation, the balloon catheter was placed into coronary arteries of seven living pigs, and the MGd and trypan blue mixture was infused into arterial walls with MR guidance. Signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of coronary artery walls were recorded by using different coils between pre-and postcontrast infusion, with subsequent histologic confirmation. Paired Student t tests were used to compare average SNRs and CNRs of arterial walls before and after contrast agent infusion with different coils.Results: SMCs could take up MGd with the optimal concentration at 150 mu mol/L. Average SNR with the MR imaging guidewire and surface coil combination was significantly higher than that with the MR imaging guidewire only or with surface coils only (P < .05), and average SNR and CNR of postinfusion MR imaging was significantly higher than that of preinfusion MR imaging (P < .05). Histologic analysis was used to confirm successful intracoronary infiltration of MGd and trypan blue within coronary artery walls.Conclusion: MR imaging can be used to delineate locally infused contrast agent distribution in coronary artery walls. This establishes groundwork for development of molecular MR imaging-guided intracoronary therapy. (C) RSNA, 2013

Toward MRI-guided coronary catheterization: visualization of guiding catheters, guidewires, and anatomy in real time.

MRI-guided coronary catheterization and PTCA: A feasibility study on a dog model.

Intracoronary MR imaging using a 0.014-inch MR imaging-guidewire: toward MRI-guided coronary interventions.

Real-time projection MR angiography: feasibility study.

Real-time magnetic resonance imaging – guided coronary intervention in a porcine model

Development of A 0.014-Inch Magnetic Resonance Imaging Guidewire

Remote control catheter navigation: options for guidance under MRI

Intravascular MR Imaging and Intravascular MR-guided Interventions.

Intravascular 3.0 T MRI Using an Imaging-Guidewire: a Feasibility Study in Swine

3.0-T Mr Imaging of Intracoronary Local Delivery of Motexafin Gadolinium into Coronary Artery Walls

Fast, automated, real-time 3D passive balloon catheter tracking during MRI-guided cardiac catheterization using orthogonal projection imaging and real-time image-based catheter detection

Magnetic Navigation In Ultrasound-Guided Interventional Radiology Procedures

MRI in guiding and assessing intramyocardial therapy

Development of a 0.014-in., anti-solenoid loop MR imaging guidewire for intravascular 3.0-T MR imaging.

Thermal Effect of Intravascular MR Imaging Using an MR Imaging-Guidewire: an in Vivo Laboratory and Histopathological Evaluation.

Real-Time High-Resolution MRI Endoscopy at up to 10 Frames per Second

Clinical 3.0 T Magnetic Resonance Scanner to Be Used for Imaging of Mouse Atherosclerotic Lesions

MRI Robots for Needle-Based Interventions: Systems and Technology

High-resolution MRI of deep-seated atherosclerotic arteries using motexafin gadolinium.

Intracoronary 3.0T MRI: An ex vivo feasibility study in swine hearts

Visualization and Characterization of Atherosclerotic Plaques by Micro-MRI at 4.7 T In Vivo and 11.7 T Ex Vivo